Adnexus raises $15.5 million
August 9, 2007 08:41 AM
E-mail|
|Comments
()|
Text size
–
+
Adnexus Therapeutics Inc. announced today that it has raised $15.5 million through a private placement of Series C preferred stock.
The Waltham-based company is focused on generating medicines through the discovery, development, and commercialization of a new class of drugs called Adnectins.
Adnexus said the round was led by a new investor, HBM BioVentures (Cayman) Ltd., a global healthcare investment firm.
(By Chris Reidy, Globe staff)
Comment
Permalink
E-mail
